Literature DB >> 24055164

Treatment-related harms: what was planned and what was reported? National Cancer Institute's Co-operative group phase III randomized controlled trials: a systematic review.

Rahul S Mhaskar1, Tea Reljic2, Hesborn Wao2, Ambuj Kumar3, Branko Miladinovic2, Benjamin Djulbegovic3.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24055164     DOI： 10.1016/j.jclinepi.2013.07.006

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN： 0895-4356            Impact factor:   6.437


× No keyword cloud information.
  2 in total

1.  The relationship between eligibility criteria and adverse events in randomized controlled trials of hematologic malignancies.

Authors:  A Statler; T Radivoyevitch; C Siebenaller; A T Gerds; M Kalaycio; E Kodish; S Mukherjee; C Cheng; M A Sekeres
Journal:  Leukemia       Date:  2016-12-07       Impact factor: 11.528

Review 2.  Systematic review of the empirical evidence of study publication bias and outcome reporting bias - an updated review.

Authors:  Kerry Dwan; Carrol Gamble; Paula R Williamson; Jamie J Kirkham
Journal:  PLoS One       Date:  2013-07-05       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.